Testing effectiveness (Phase 2)UnknownNCT02488707
What this trial is testing
Minimally Invasive Sphincter Sparing Total Mesorectal Excision for Ultra-low Rectal Cancer After Initial Chemo-radiotherapy (MISS-TRICR).
Who this might be right for
Rectal Cancer
Mansoura University 250